en
Scientific article
English

Alzheimer Disease Biomarkers as Outcome Measures for Clinical Trials in MCI

Publication date2014
Abstract

Aim of this study was to compare the performance and power of the best-established diagnostic biological markers as outcome measures for clinical trials in patients with mild cognitive impairment (MCI).

Citation (ISO format)
CAROLI, Anna et al. Alzheimer Disease Biomarkers as Outcome Measures for Clinical Trials in MCI. In: Alzheimer disease and associated disorders, 2014. doi: 10.1097/WAD.0000000000000071
Main files (1)
Article (Accepted version)
accessLevelRestricted
Identifiers
ISSN of the journal0893-0341
519views
1downloads

Technical informations

Creation12/15/2014 10:37:00 AM
First validation12/15/2014 10:37:00 AM
Update time03/14/2023 11:02:32 PM
Status update03/14/2023 11:02:31 PM
Last indexation01/16/2024 5:24:24 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack